Renalytix PLC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

OQB
Icahn School of Medicine at Mount Sinai acquired 13,366,750 Ordinary Shares of Renalytix plc in a private placement, increasing its holdings.
OQB
Interim Chief Financial Officer of Renalytix plc, Joel R Jung, reports acquisition of employee stock options.
OQB
Icahn School of Medicine at Mount Sinai acquired 9,360,374 Ordinary Shares of Renalytix plc as part of the second tranche of a private placement.